Evidence map›Paper›PMID 29093083›Full record

ArticleJournal of virology2018

Dynamics of Sendai Virus Spread, Clearance, and Immunotherapeutic Efficacy after Hematopoietic Cell Transplant Imaged Noninvasively in Mice.

Heba H Mostafa, Peter Vogel, Ashok Srinivasan, Charles J Russell

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. NK cells: A double edge sword against SARS-CoV-2.Advances in biological regulation · 2020
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Heba H MostafaDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Peter VogelDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Ashok SrinivasanDepartment of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee, USA ashok.srinivasan@stjude.org charles.russell@stjude.org.
Charles J RussellDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee, USA ashok.srinivasan@stjude.org charles.russell@stjude.org.
St. Jude Children's Research Hospital · USUniversity of Tennessee Health Science Center · US

Funding

Molecular basis for parainfluenza virus infection and host responseR01AI083370 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI RUSSELL, CHARLES JOHN · 2010 to 2014
$1.9M
NIAID NIH HHS R01 AI083370
6 · The paper itself

Abstract

There are no approved vaccines or virus-specific treatments for human parainfluenza viruses (HPIVs), which have recently been reclassified into the species

Indexed as

Adoptive TransferAnimalsAntibodies, MonoclonalAntibodies, ViralFemaleGranulocyte Colony-Stimulating FactorHematopoietic Stem Cell TransplantationImmunotherapyLuminescent MeasurementsLymphocyte CountMiceNeutrophilsRespirovirus InfectionsSendai virusSeverity of Illness IndexT-Lymphocyte SubsetsAntibodies, MonoclonalAntibodies, ViralGranulocyte Colony-Stimulating Factorbioluminescence imagingbone marrow transplantationhematopoietic cell transplantimmunotherapyparainfluenza virusSendai virus

Identifiers

PMID29093083
PMCPMC5752929
OpenAlexW2766147258

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.